Abstract | OBJECTIVE: METHODS: We enrolled 18 patients (6 girls and 12 boys) who met the following criteria: 1) the age of onset of the seizures was between 3 and 13 years of age; 2) showing at least hemifacial and/or oropharyngeal seizures; 3) interictal discharges in central and/or middle temporal electrodes; 4) no intellectual disability; 5) treatment duration of lacosamide monotherapy over 6 months. We retrospectively collected and analyzed clinical data and treatment information. We evaluated the seizure occurrences during 0-3, 4-6, and 7-12 months from the treatment initiation and the last 6 months of the follow-up. We also evaluated the outcomes as seizure-free if the patients developed no seizures both over 6 months and 3 times of pretreatment mean seizure interval at the last follow-up. RESULTS: Of the patients, 39%, 67% and 72% were seizure-free during 0-3, 4-6, and 7-12 months from treatment initiation, respectively. Finally, 83% of the patients achieved seizure freedom. Seizure freedom was achieved in 72% during the first 4 months of treatment. All patients continued lacosamide monotherapy during the study, although four patients showed transient fatigue or somnolence. CONCLUSIONS:
Lacosamide showed good efficacy for controlling seizures with fewer adverse effects, and therefore may be a good candidate as a first-line medication for the treatment of new-onset CECTS.
|
Authors | Tohru Okanishi, Yuji Fujii, Satoru Sakuma, Hideaki Shiraishi, Hirotaka Motoi, Kotaro Yazaki, Hideo Enoki, Ayataka Fujimoto |
Journal | Brain & development
(Brain Dev)
Vol. 44
Issue 6
Pg. 380-385
(Jun 2022)
ISSN: 1872-7131 [Electronic] Netherlands |
PMID | 35241306
(Publication Type: Journal Article)
|
Copyright | Copyright © 2022 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved. |
Chemical References |
- Anticonvulsants
- Lacosamide
|
Topics |
- Anticonvulsants
- Epilepsies, Partial
(drug therapy)
- Female
- Humans
- Infant
- Lacosamide
(therapeutic use)
- Male
- Retrospective Studies
- Seizures
(drug therapy)
- Treatment Outcome
|